Arena Capital Advisors’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-300,000
| Closed | -$3.03M | – | 158 |
|
|
2022
Q4 | $3.03M | Hold |
300,000
| – | – | 1.65% | 22 |
|
|
2022
Q3 | $2.98M | Hold |
300,000
| – | – | 0.9% | 36 |
|
|
2022
Q2 | $2.97M | Hold |
300,000
| – | – | 0.75% | 46 |
|
|
2022
Q1 | $2.96M | Hold |
300,000
| – | – | 0.45% | 79 |
|
|
2021
Q4 | $2.95M | Hold |
300,000
| – | – | 0.27% | 119 |
|
|
2021
Q3 | $2.92M | Buy |
300,000
+202,728
| +208% | +$1.97M | 0.23% | 136 |
|
|
2021
Q2 | $941K | Buy |
+97,272
| New | +$941K | 0.08% | 246 |
|